Dual noninvasive testing (HeartCare) after HTX improved performance for ACR surveillance (vs single molecular testing) and reduce biopsy rates with excellent survival: insights from SHORE registry https://t.co/zNWFzOJj5E
453 followers
1,181 followers
How does your heart transplant program approach scheduling post transplant endomyocardial biopsies vs noninvasive monitoring? This paper looked at outcomes from the SHORE registry with both gene expression profiling and dd-cfDNA data! #ManuscriptMonday ht
2,917 followers
RT @JeffTeuteberg: 🚨1st SHORE pub‼️ > 2k🫀transplants, dual non-invasive rejection surveillance with GEP & dd-cfDNA: 1. ⬆️yield for ACR over…
2,360 followers
Great data and time to limit use of EMBx